BioAge Labs (BIOA) Gains from Investment Securities (2024 - 2026)
BioAge Labs' (BIOA) quarterly Gains from Investment Securities came in at $201000.0 in Q2 2026, up 1727.27% year-over-year from $11000.0 in Q2 2025, and up 87.85% quarter-over-quarter from $107000.0 in Q1 2026.
Powered by 
Analysis
BioAge Labs (BIOA) Gains from Investment Securities (2024 - 2026) Analysis & Trends
BioAge Labs has disclosed Gains from Investment Securities across 3 years of filings, most recently posting $201000.0 for Q2 2026.
- In Q2 2026, Gains from Investment Securities rose 1727.27% year-over-year to $201000.0; the TTM figure through Jun 2026 stood at $570000.0 (up 386.43% YoY), while the FY2025 annual figure was $214000.0, up 393.15% from the prior year.
- Gains from Investment Securities came in at $201000.0 for Q2 2026 at BioAge Labs, up from $107000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $306000.0 in Q3 2024 to a low of -$457000.0 in Q4 2024.
- Average Gains from Investment Securities over 3 years is $44900.0, with a median of $56000.0 recorded in 2024.
- Year-over-year, Gains from Investment Securities sank 837.5% in 2025 and soared 1727.27% in 2026.
- Over 3 years, Gains from Investment Securities stood at -$457000.0 in 2024, then surged by 148.14% to $220000.0 in 2025, then slipped by 8.64% to $201000.0 in 2026.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were $201000.0 in Q2 2026, $107000.0 in Q1 2026, and $220000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioAge Labs | 439.00 Mn | 439.00 Mn | -14.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 201,000.00 |
| Mar 31, 2026 | 107,000.00 |
| Dec 31, 2025 | 220,000.00 |
| Sep 30, 2025 | 42,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | -59,000.00 |
| Dec 31, 2024 | -457,000.00 |
| Sep 30, 2024 | 306,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 8,000.00 |